BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 19305025)

  • 1. [Variable clinical expression of familial Incontinentia Pigmenti syndrome - presentation of three cases].
    Kutkowska-Kaźmierczak A; Obersztyn E; Bonnefont JP; Rosińska-Borkowska D; Mazurczak T; Sobczyńska-Tomaszewska A; Mazurczak T
    Med Wieku Rozwoj; 2008; 12(3):748-53. PubMed ID: 19305025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incontinentia pigmenti (Bloch-Sulzberger syndrome).
    Narayanan MJ; Rangasamy S; Narayanan V
    Handb Clin Neurol; 2015; 132():271-80. PubMed ID: 26564087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incontinentia pigmenti (Bloch-Sulzberger syndrome): a systemic disorder.
    Ehrenreich M; Tarlow MM; Godlewska-Janusz E; Schwartz RA
    Cutis; 2007 May; 79(5):355-62. PubMed ID: 17569396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incontinentia pigmenti (Bloch-Sulzberger syndrome)].
    Mühlenstädt E; Eigelshoven S; Hoff NP; Reifenberger J; Homey B; Bruch-Gerharz D
    Hautarzt; 2010 Oct; 61(10):831-3. PubMed ID: 20865235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NEMO gene mutations in Chinese patients with incontinentia pigmenti.
    Hsiao PF; Lin SP; Chiang SS; Wu YH; Chen HC; Lin YC
    J Formos Med Assoc; 2010 Mar; 109(3):192-200. PubMed ID: 20434027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel PCR approach for prenatal detection of the common NEMO rearrangement in incontinentia pigmenti.
    Steffann J; Raclin V; Smahi A; Woffendin H; Munnich A; Kenwrick SJ; Grebille AG; Benachi A; Dumez Y; Bonnefont JP; Hadj-Rabia S
    Prenat Diagn; 2004 May; 24(5):384-8. PubMed ID: 15164415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incontinentia Pigmenti.
    Cammarata-Scalisi F; Fusco F; Ursini MV
    Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):273-278. PubMed ID: 30660327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Proposal for a protocol for the staging of incontinentia pigmenti in pediatric age].
    Portaleone D; Taroni F; Micheli S; Moioli M; Pedrazzini A; Cognizzoli P; Carnelli V
    Minerva Pediatr; 2007 Jun; 59(3):255-65. PubMed ID: 17519871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo NEMO gene deletion (delta4-10)--a cause of incontinentia pigmenti in a female infant: a case report.
    Culić V; Gabrić D; Puizina-Ivić N; Rozman K; Peterlin B; Pavelić J
    Coll Antropol; 2008 Dec; 32(4):1259-62. PubMed ID: 19149237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical diagnosis of incontinentia pigmenti in a cohort of male patients.
    Fusco F; Fimiani G; Tadini G; Michele D; Ursini MV
    J Am Acad Dermatol; 2007 Feb; 56(2):264-7. PubMed ID: 17224368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incontinentia pigmenti.
    Motamedi MH; Lotfi A; Azizi T; Moshref M; Farhadi S
    Indian J Pathol Microbiol; 2010; 53(2):302-4. PubMed ID: 20551538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Two neonates with vesicular skin lesions due to incontinentia pigmenti].
    Winterberg DH; van Tijn DA; Smitt JH; Winterberg S; Vomberg PP
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2178-82. PubMed ID: 11727618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [NEMO Delta 4-10 deletion of NEMO gene in Chinese incontinentia pigmenti cases].
    Li L; Song GW; DU JB; Liu JR; Xu FS; Liu XY; Zhang T
    Zhonghua Er Ke Za Zhi; 2005 Feb; 43(2):89-92. PubMed ID: 15833158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium.
    Smahi A; Courtois G; Vabres P; Yamaoka S; Heuertz S; Munnich A; Israël A; Heiss NS; Klauck SM; Kioschis P; Wiemann S; Poustka A; Esposito T; Bardaro T; Gianfrancesco F; Ciccodicola A; D'Urso M; Woffendin H; Jakins T; Donnai D; Stewart H; Kenwrick SJ; Aradhya S; Yamagata T; Levy M; Lewis RA; Nelson DL
    Nature; 2000 May; 405(6785):466-72. PubMed ID: 10839543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incontinentia Pigmenti: A Summary Review of This Rare Ectodermal Dysplasia With Neurologic Manifestations, Including Treatment Protocols.
    Greene-Roethke C
    J Pediatr Health Care; 2017; 31(6):e45-e52. PubMed ID: 28870493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An incontinentia pigmenti family with deletion in both NEMO gene and pseudogene DeltaNEMO].
    Zhang G; Shi H; Du X; Shao M; Zhou Q
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):573-5. PubMed ID: 18841575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incontinentia pigmenti. Four patients with different clinical manifestations].
    Llano-Rivas I; Soler-Sánchez T; Málaga-Diéguez I; Fernández-Toral J
    An Pediatr (Barc); 2012 Mar; 76(3):156-60. PubMed ID: 22036144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal white matter in a neurologically intact child with incontinentia pigmenti.
    Bryant SA; Rutledge SL
    Pediatr Neurol; 2007 Mar; 36(3):199-201. PubMed ID: 17352958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The common NF-κB essential modulator (NEMO) gene rearrangement in Korean patients with incontinentia pigmenti.
    Song MJ; Chae JH; Park EA; Ki CS
    J Korean Med Sci; 2010 Oct; 25(10):1513-7. PubMed ID: 20890435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incontinentia pigmenti with ultrastructurally disordered leucocytes.
    Minić S; Trpinac D; Obradović M; Novotny GE; Gabriel HD; Kuhn M
    J Clin Pathol; 2010 Jul; 63(7):657-9. PubMed ID: 20591917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.